Evidence map›Paper›PMID 25264749›Full record

ArticleJournal of cardiovascular pharmacology2015

Saxagliptin restores vascular mitochondrial exercise response in the Goto-Kakizaki rat.

Amy C Keller, Leslie A Knaub, Matthew W Miller, Nicholas Birdsey, Dwight J Klemm, Jane E B Reusch

Abstract read
In one paragraph

Article in Journal of cardiovascular pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Reviewing physical exercise in non-obese diabetic Goto-Kakizaki rats.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amy C Keller*Division of Endocrinology, Metabolism and Diabetes, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO; †Department of Medicine, Denver VA Medical Center, Denver, CO; and ‡Division of Pulmonary Sciences and Critical Care Medicine, Cardiovascular Pulmonary Research, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO.
Leslie A Knaub
Matthew W Miller
Nicholas Birdsey
Dwight J Klemm
Jane E B Reusch
University of Colorado Anschutz Medical Campus · USDenver VA Medical Center · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
Translational Pulmonary Vascular Biology ProgramT32HL007171 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Sonia Castro Flores, Tim Lahm · 1985 to 2026
$9.4M
Targeting Microvascular Contributors to Impaired Functional Exercise Capacity in DiabetesI01BX002046 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI REUSCH, JANE E · 2014 to 2024
–
BLRD VA I01 BX002046CSRD VA I01 CX001532NCATS NIH HHS UL1 TR001082NCRR NIH HHS UL1 RR025780NCRR NIH HHS UL1RR025780NHLBI NIH HHS 5P01HL014985NHLBI NIH HHS 5T32HL007171NHLBI NIH HHS P01 HL014985NHLBI NIH HHS T32 HL007171
6 · The paper itself

Abstract

Cardiovascular disease risk and all-cause mortality are largely predicted by physical fitness. Exercise stimulates vascular mitochondrial biogenesis through endothelial nitric oxide synthase (eNOS), sirtuins, and PPARγ coactivator 1α (PGC-1α), a response absent in diabetes and hypertension. We hypothesized that an agent regulating eNOS in the context of diabetes could reconstitute exercise-mediated signaling to mitochondrial biogenesis. Glucagon-like peptide 1 (GLP-1) stimulates eNOS and blood flow; we used saxagliptin, an inhibitor of GLP-1 degradation, to test whether vascular mitochondrial adaptation to exercise in diabetes could be restored. Goto-Kakizaki (GK) rats, a nonobese, type 2 diabetes model, and Wistar controls were exposed to an 8-day exercise intervention with or without saxagliptin (10 mg·kg·d). We evaluated the impact of exercise and saxagliptin on mitochondrial proteins and signaling pathways in aorta. Mitochondrial protein expression increased with exercise in the Wistar aorta and decreased or remained unchanged in the GK animals. GK rats treated with saxagliptin plus exercise showed increased expression of mitochondrial complexes, cytochrome c, eNOS, nNOS, PGC-1α, and UCP3 proteins. Notably, a 3-week saxagliptin plus exercise intervention significantly increased running time in the GK rats. These data suggest that saxagliptin restores vascular mitochondrial adaptation to exercise in a diabetic rodent model and may augment the impact of exercise on the vasculature.

Indexed as

Diabetes Mellitus, Type 2Mitochondria, MuscleMotor ActivityAdamantaneAnimalsDipeptidesDipeptidyl-Peptidase IV InhibitorsDisease Models, AnimalGlucagon-Like Peptide 1Mitochondrial ProteinsMuscle, Smooth, VascularNitric Oxide Synthase Type IIIOrganelle BiogenesisPhysical Conditioning, AnimalRatsTreatment OutcomeAdamantaneDipeptidesDipeptidyl-Peptidase IV InhibitorsGlucagon-Like Peptide 1Mitochondrial ProteinsNitric Oxide Synthase Type IIIsaxagliptin

Identifiers

PMID25264749
PMCPMC4320657
OpenAlexW1992453950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.